ArticleScientific reports2026
Neuronal silence as a predictive biomarker and target for epileptic seizures suppression.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- New directions for complex systems in contemporary neuroscience: a morphodynamic and emergent function approach.Frontiers in computational neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Epilepsy is a prevalent neurological disorder marked by abnormal synchronized neuronal firing, which can often lead to long-term cognitive and physical impairments. In this work, we introduce a reliable biomarker for seizure prediction. Through simulations of a conductance-based neuronal network model that reproduces spontaneous seizure-like events, we identify that slow potassium channels play an important role in seizure generation. Our key finding is the consistent presence of a prolonged period of neuronal silence that precedes the seizure onset, establishing it as a physiologically relevant biomarker for seizure prediction. Notably, this silence is also identified in human electrophysiological data, confirming its physiological and clinical relevance. Based on this biomarker, we develop a targeted suppression strategy that, in our simulations, significantly shortens long seizure duration by up to 93%. Our results establish the network silence as a predictive and clinically translatable biomarker for seizure dynamics, opening new avenues for improved forecasting and personalized neuromodulation therapies in epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.